, isolated from the Red Sea sponge Hemimycale arabica, and δ-tocotrienol (3), isolated from the tocotrienol-rich fraction of palm oil, are important antimetastatic and antiproliferative natural products that proved effective against metastatic prostate and breast cancers, respectively. New fluorescent derivatives of PMH (2) and δ-tocotrienol (4) were synthesized by Steglich esterification. Both 2 and 4 retained good anti-migratory and antiproliferative activities, respectively. Fluorescent analogues 2 and 4 can be used for the identification of molecular targets of 1 and 3 in tumor cell cultures.
Prostate and breast cancers are the second most important killer in men and women, respectively [1a,1b] . More than half of today's anticancer drugs are based on natural products [1a,1b] . Molecular target identification is important for drug discovery and lead optimization. Fluorescent labeling is a commonly used tagging method due to its simplicity, sensitivity, advances in microscopy and imaging, and convenient handling [1c] .
In the present study, coumarin tagging was selected to label two bioactive natural products, 4-hydroxyphenylmethylene hydantoin (PMH, 1) and δ-tocotrienol (3). Coumarins have high emission yield, extended spectral range, photo-stability, and reasonable solubility in common solvents [1d] .
The Red Sea sponge Hemimycale arabica (Mycalidae) is the natural source of (Z)-5-(4-hydroxybenzylidene)imidazolidine-2,4-dione (1) [1e] . Compound 1 showed potent anti-invasive and anti-metastatic activities against prostate cancer in vitro and in orthotopic xenograft and LPB-tag transgenic mice models [1e,1f] .
Vitamin E is the generic name of both tocotrienols and tocopherols. Each group is composed of four isomers namely; α, β, γ, and δ-tocopherols or tocotrienols. Tocotrienols inhibit the growth of human breast cancer cells in vitro and in vivo through estrogen-independent mechanisms [2a] . δ-Tocotrienol contributes most towards breast cancer versus other tocotrienols because it is the most potent apoptosis inducer, and pre-neoplastic and malignant cells proliferation inhibitor [2b].
Further developments of PMHs and tocotrienols as possible anticancer drugs are pending on the identification of their specific molecular target(s). Preparation of their fluorescent derivatives would enable direct in vivo visualization of molecular target(s) in tumor cell cultures by fluorescence microscopy, providing clear insights into their anticancer mechanisms.
New fluorescent analogues of PMH and δ-tocotrienol (2 and 4, respectively) were synthesized by esterification of their phenolic hydroxy group with 7-(diethylamino)-2-oxo-2H-chromene-3-carboxylic acid. PMH 1 was initially isolated from H. arabica and later synthesized using base-catalyzed aldol condensation of 4-hydroxybenzaldehyde with hydantoin [1e]. The Steglich esterification reaction was used to esterify the phenolic hydroxyl groups of 1 and 3 with the fluorescent coumarin dye 7-(diethylamino)-2-oxo-2H-chromene-3carboxylic acid, using 4-dimethylaminopyridine (DMAP) and dicyclohexylcarbodiimide (DCC) as catalysts [3a,3b] . The HRMS of 2 showed a molecular ion peak (M+Na) + at m/z 470.1328, suggesting the molecular formula C 24 H 21 N 3 O 6 . Esterification of phenols is expected to shift the UV absorption to shorter wavelength and decrease the absorption intensity [3c]. UV spectra of 2 showed a hypsochromic shift of the peak at λ max 337.4 nm to 317.9 nm with peak intensity reduction. The new peak at 429.3 nm suggested its conjugation with the newly introduced fluorophore. This was better illustrated in the excitation and emission spectra of 2.
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Analysis of the 1 H and 13 C NMR spectroscopic data of 2 (Table 1) suggested C-10 phenol esterification. The downfield shift of carbons C-9 and C-11 and the upfield shift of C-10 (Δδ + 5.7, 5.7 and -8.2, respectively), as compared with the parent 1, indicated C-10 esterification. The proton singlet H-4' (δ Η 8.58) showed 3 J-HMBC correlations with the ester carbonyl carbon (δ C 162.8), and carbons C-1' (the coumarin ring δ-lactone carbonyl, δ C 158.9), C-5' (δ C 131.7), and C-9' (δ C 158.7). Similarly, the proton doublet H-5' (δ Η 7.38) showed 3 J-HMBC correlations with the quaternary carbons C-7' (δ C 153.8) and C-9', in addition to the methine carbon C-4' (δ C 150.9). Proton H-6' (δ Η 6.61) showed 3 J-HMBC correlations with C-8' and C-10' (δ C 96.7 and 107.9, respectively). Protons H-5' and H-6' also showed COSY correlations to each other. The methylene quartet (δ H 3.43) of the diethylamino group showed COSY coupling with the methyl triplet at δ 1.20 and 3 J-HMBC correlations with the quaternary carbon C-7'.
The HRMS of 4 showed a molecular ion peak (M+Na) + at m/z 662.3820, suggesting the molecular formula C 41 H 53 N 1 O 5 and successful esterification of 3. The UV spectra of 3 and 4 shows a peak at λ max 297.1 nm for the aromatic ring, which was hypsochromic shifted to 262.1 nm as a result of C-6 esterification. The new peak at λ max 424.0 nm (4) is attributed to its conjugation with the fluorescent dye [3d].
Most of the 1 H and 13 C NMR spectroscopic data of 4 showed close similarity to those of the parent δ-tocotrienol (3). The downfield shift of protons H-5 and H-7 (Δδ +0.31 and 0.27, respectively) suggested possible esterification at C-6. The downfield shift of carbons C-5 and C-7 and the upfield shift of C-6 (Δδ + 6.7, 5.7, and -5.3, respectively) as compared with the parent 3, further supported this conclusion.
Esterification of the C-10 hydroxyl group of 1 with a coumarin dye that contains a distal diethylamino group should maintain some activity. It was chosen to mimic the distal region, containing a diethylamino group at C-7 of the chromen ring, of the known active (Z)-5-(4-(diethylamino)benzylidene)imidazoliine-2,4-dione [1e]. Similarly, the isoprenyl chain and chroman ring are the most important pharmacophores for the antiproliferative and apoptotic activity of tocotrienols [3d]. The relative biopotency of tocotrienols is in the following order; δ-≥ γ->β->α->tocopherol isomers [3d]. Therefore, esterification of the C-6 hydroxyl group of δ-tocotrienol was selected for the fluorescent tagging. δ-Tocotrienol was preferred because it is the most active tocotrienol isomer and has the least sterically hindered C-6 hydroxyl group. 50 μM in prostate cells [1e,1f] . Therefore, the fluorescent-tagged ester 2 was tested in PC-3 cells starting at this dose to evaluate its effect against proliferation in the the MTT assay, and also to assess its comparative anti-migratory effect in the wound-healing assay. Figure 1 suggests that compound 2 does not possess any significant cytotoxic effect at this dose, and retained its ability to reverse the action of CT promoted disruption of TJs and AJs similar to that of the parent compound 1. Figure 2 shows dose dependent antimigratory activity of 2. The primary pharmacological action of δ-tocotrienol is the inhibition of breast cancer cell proliferation. Therefore, fluorescent-tagged δ-tocotrienol (4) was tested for its ability to inhibit the proliferation of the highly malignant +SA mammary epithelial cells in MTT assay. In summary, 2 and 4 are new fluorescent analogues of the anticancer natural products 1 and 3. These compounds will aid mechanistic and exact molecular target(s) identification studies of the natural product classes PMHs and tocotrienols.
Experimental
General experimental procedure: NMR, JEOL Eclipse NMR spectrometer; IR, Varian 800 FT-IR spectrophotometer; TLC, precoated Si gel G 254 500 μm TLC plates (E-Merck); CC, Si gel 60 (Natland, 63-200 μm); HREIMS, Micromass LCT spectrometer (University of Michigan).
Reaction of 7-(diethylamino)-2-oxo-2H-chromene-3carboxylic acid with 1 and 3:
To a solution of 1 (0.035 g, 0.172 mmol) in DMF was added 7-(diethylamino)-2oxo-2H-chromene-3-carboxylic acid solution (0.022 g, 0.084 mmol) in DMF [3a,3b] . 4-DMAP (0.010 g, 0.08 mmol) was then added to the mixture (Scheme 1). The solution was then cooled in an ice bath (0 o C) while 0.07 g (0.34 mmol) of DCC was slowly added [3a,3b] . The residue was subjected to CC, and gradiently eluted with MeOH-CHCl 3 to afford 2. To a solution of 3 (30 mg, 0.126 mmol, Scheme 1) and 7-(diethylamino)-2-oxo-2H-chromene-3-carboxylic acid (15 mg, 0.126 mmol) in CH 2 Cl 2 (2.5 mL), DCC (77.4 mg, 0.63 mmol) and DMAP (9.5 mg, 0.126 mmol) were added [3a,3b] . The mixture was stirred at room temperature for 30 h. The reaction mixture was treated with 10 mL H 2 O, filtered and then extracted with CH 2 Cl 2 . The dry CH 2 Cl 2 extract (123 mg) was subjected to normal phase CC over Si gel 60 using n-hexane-EtOAc gradient elution to afford 4.
Cell proliferation assay:
The MTT kit was purchased from TACS TM , TREVIGEN ® , Inc., Gaithersburg, MD. The proliferation of prostate cancer cells was determined as described by Shah et al. [1f] . 
